Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anicom Advanced Medical Research Institute is a specialized biotechnology company focused on the development of advanced veterinary therapies for companion animals. As a subsidiary of Anicom Holdings, the institute leverages extensive pet health data to pioneer regenerative medicine, specifically utilizing mesenchymal stem cells to treat chronic feline and canine diseases. Their portfolio includes clinical applications for chronic kidney disease, inflammatory bowel disease, and various ophthalmic conditions. Beyond cell therapy, the institute provides comprehensive genetic testing and microbiome analysis services aimed at preventive pet healthcare. By integrating research with clinical practice through a network of animal hospitals, they facilitate the rapid translation of laboratory findings into veterinary treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anicom Advanced Medical Research Institute.